Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pioglitazone hydrochloride (AD 4833) 是一种选择性PPARγ激动剂,高亲和力结合到 PPARγ 配体结合域。作用于人和鼠 PPARγ,EC50分别为 0.93 和 0.99 μM。它是一种口服活性噻唑烷二酮的盐酸盐,具有抗糖尿病特性和潜在的抗肿瘤活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 155 | 现货 | ||
100 mg | ¥ 198 | 现货 | ||
500 mg | ¥ 570 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 218 | 现货 |
产品描述 | Pioglitazone hydrochloride (AD 4833) is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. |
靶点活性 | PPARγ (mouse):0.99 μM (EC50), PPARγ (human):0.93 μM (EC50) |
体外活性 | 在雄性肥胖鼠中,口服 Pioglitazone(0.3-3 mg/kg)7天,能够以剂量依赖性的方式地降低高血糖症,高脂血症,和高胰岛素血症. |
体内活性 | Pioglitazone 通过抑制iNOS的表达和NO的产生,保护多巴胺能神经元被LPS损伤。Pioglitazone也能够抑制脂多糖诱导的p38蛋白磷酸化。 |
细胞实验 | In order to evaluate cell proliferation, HIT-T15 cells are seeded on 96-well plates (3×104 cells/well) and cultured for 5 days as described. Viable cells are determined using the Cell Titer 96 Aqueous One Solution Cell Proliferation Assay. To evaluate cell apoptosis and cell necrosis, HIT-T15 cells are plated on 6-well dishes (7×105 cells/well) for 5 days in standard conditions (CTR) or in the presence of AGEs (AGEs) with or without Pioglitazone (0.5 or 1 μM) or AG (1 mM). They are then processed to measure both the activity of caspase-3 and the activity of lactate dehydrogenase (LDH) (a stable cytosolic enzyme that is a marker of cell membrane damage and cell death due to necrosis) using Cytotox 96 Non Radioactive Cytotoxicity Assay[2]. |
别名 | U-72107E, AD 4833, U 72107A, Pioglitazone HCl, 匹格列酮盐酸盐 |
分子量 | 392.9 |
分子式 | C19H20N2O3S·HCl |
CAS No. | 112529-15-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9.8 mg/mL (25 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5452 mL | 12.7259 mL | 25.4518 mL | 63.6294 mL |
5 mM | 0.509 mL | 2.5452 mL | 5.0904 mL | 12.7259 mL | |
10 mM | 0.2545 mL | 1.2726 mL | 2.5452 mL | 6.3629 mL | |
20 mM | 0.1273 mL | 0.6363 mL | 1.2726 mL | 3.1815 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Pioglitazone hydrochloride 112529-15-4 Apoptosis DNA Damage/DNA Repair Metabolism Ferroptosis PPAR U-72107E AD 4833 Inhibitor Pioglitazone inhibit AD-4833 U 72107A Pioglitazone HCl 匹格列酮盐酸盐 Pioglitazone Hydrochloride Peroxisome proliferator-activated receptors AD4833 inhibitor